SRRK
SRRK
NASDAQ · Biotechnology

Scholar Rock Holding Corp

$42.30
-1.36 (-3.12%)
As of Mar 24, 9:54 PM ET ·
Analyst Consensus
Strong Buy
22
Analysts
High
Coverage
Buy 21 95%
Hold 1 5%
Sell 0 0%
Price Target
Analyst Price Target +68.5% upside
Low Target $54.07
Average Target $71.29
High Target $91.55
Current Price $42.30
Current
$42.30
Target
$71.29
$54.07 $71.29 avg $91.55
Scenario Analysis
Bear Case
$54.07
27.8%
Low target
Base Case
$71.29
+68.5%
Avg target
Bull Case
$91.55
+116.4%
High target
Risk/Reward
4.2x
Highly favorable
Price in Context
52-Week High
$49.82
-15.1% from high
52-Week Low
$22.71
+86.3% from low
50-Day SMA
$45.16
-6.3% vs SMA
200-Day SMA
$36.91
+14.6% vs SMA
RSI (14)
59.5
Neutral
Target vs 52W High
$71.29
+43.1% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 39 69% $257.58 +25.5%
AMGN
Amgen Inc
Hold 42 50% $190.87 -45.2%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +162.6%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 -2.3%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -89.6%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 78% $102.31 -66.8%
INSM
Insmed Inc
Strong Buy 26 92% $143.40 +3.1%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -26.5%